CCND1 and mantle cell lymphoma: (50) applied iron chelator deferasirox (DFX) to mantle cell lymphoma (MCL) cells, and found that DFX lead to cyclin D1 proteolysis and degradation in a mechanism that requires its phosphorylation on T286 by glycogen synthase kinase-3β (GSK3β).